The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis

The role of anti-epidermal growth factor receptor (EGFR) therapy is controversial in patients with esophago-gastric adenocarcinoma. We performed this meta-analysis to evaluate whether the addition of an anti-EGFR agent to chemotherapy can produce survival benefits in patients with advanced esophagea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bum Jun, Kim, Jung Han, Jang, Hyun Joo, Kim, Hyeong Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716788/
https://www.ncbi.nlm.nih.gov/pubmed/29228748
http://dx.doi.org/10.18632/oncotarget.20958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716788/
https://www.ncbi.nlm.nih.gov/pubmed/29228748
http://dx.doi.org/10.18632/oncotarget.20958

Ejemplares similares